COMMUNIQUÉS West-GlobeNewswire

R3 Vascular Appoints Josh Smale as its Vice President of Global Clinical and Scientific Affairs
09/07/2024
MOUNTAIN VIEW, Calif., July 09, 2024 (GLOBE NEWSWIRE) -- R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial [...]
CloudMD Completes Go-Private Transaction with CPS Capital
09/07/2024
TORONTO, July 09, 2024 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, Frankfurt: 6PH) (the “ Company ” or “ CloudMD ”), an innovative health services company transforming the delivery of care, and [...]
Superior Medical Waste Disposal Acquires Bioclean Team Inc.'s Medical Waste Customer Base
09/07/2024
Expanding Reach and Enhancing Services for Michigan Healthcare Professionals DETROIT, July 09, 2024 (GLOBE NEWSWIRE) -- Superior Medical Waste Disposal, a leading healthcare waste service provider founded in 2009, is [...]
ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy
09/07/2024
Framework to determine stimulation parameters for ONWARD ARC-EX Therapy are published in the journal Neuromodulation: Technology at the Neural Interface Peer-reviewed publication is based on results from the Up-LIFT and [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 27 - 2024
09/07/2024
Aggregated presentation by day and by market Purchases of own shares from July 1st to 5th 2024 Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 27 - 2024
09/07/2024
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 1 au 5 juillet 2024 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
Report on Carbios’ liquidity contract with Natixis ODDO BHF
09/07/2024
PRESS RELEASE REGULATED INFORMATION: ONGOING Report on Carbios’ liquidity contract with Natixis ODDO BHF Shares concerned: Carbios (ISIN code: FR0011648716) Market concerned: Euronext Growth Paris Clermont-Ferrand ( [...]
Bilan semestriel du contrat de liquidité confié à Natixis ODDO BHF
09/07/2024
COMMUNIQUÉ DE PRESSE INFORMATION REGLEMENTEE : PERMANENTE CARBIOS : Bilan semestriel du contrat de liquidité confié à Natixis ODDO BHF Titre concerné : Carbios (code ISIN FR0011648716) Marché concerné : Euronext Growth [...]
Ipsen - June 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital
09/07/2024
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Ipsen - Juin 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
09/07/2024
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
You:Flourish Sets the Stage for Growth with Announcement of New CEO
09/07/2024
Ready to Expand, LGBTQ+ Wellness Company Names Sean Patrick Harrington as CEO DENVER, July 09, 2024 (GLOBE NEWSWIRE) -- You:Flourish a Public Benefit Corporation (PBC) and digital wellness company announces the [...]
Raw Garden Launches 100% Solventless Live Rosin, Elevating Cannabis Experience
09/07/2024
Leading cannabis brand introduces new line of live rosin made from ice, water, and pressure SANTA BARBARA, Calif., July 09, 2024 (GLOBE NEWSWIRE) -- Raw Garden , the #1 cannabis concentrates brand in California, is [...]
Curium Submits New Drug Application for Lutetium Lu 177 Dotatate Injection
09/07/2024
ST. LOUIS, July 09, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has submitted its 505(b)(2) New Drug Application for Lutetium Lu 177 Dotatate Injection, which, if [...]
Nation's Leading B2B Show for the Cannabis Industry Coming to the St. Paul River Center in August 2024
09/07/2024
CannaCon Hosting the 5th CannaCon Midwest St.Paul ST. PAUL, Minn., July 09, 2024 (GLOBE NEWSWIRE) -- via CannabisNewsWire (“CNW”) — CannaCon , a premier conference company that produces state-of-the-art B2B events for [...]
Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering
09/07/2024
CHATHAM, N.J., July 09, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced it has entered into a [...]
Neha Motwani Elected to Longeveron® Board of Directors
09/07/2024
MIAMI, July 09, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]
Myriad Genetics Announces Second Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
09/07/2024
SALT LAKE CITY, July 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the United States Patent and Trademark Office has issued [...]
Aviv Clinics Spotlights New Study Sharing Further Evidence That Specific Hyperbaric Oxygen Therapy is Effective in Fighting Aging
09/07/2024
This new study focused on physical enhancement in aging adults follows two studies related to cognitive decline and biological aging, showing the potential dedicated protocol of hyperbaric oxygen therapy has to change [...]
Zevra Announces FDA Advisory Committee Meeting to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C
09/07/2024
Meeting with the recently formed GeMDAC set for August 2, 2024 CELEBRATION, Fla., July 09, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company [...]

Pages